| Original language | English (US) |
|---|---|
| Pages (from-to) | 592-593 |
| Number of pages | 2 |
| Journal | JAMA oncology |
| Volume | 3 |
| Issue number | 5 |
| DOIs | |
| State | Published - 2017 |
Fingerprint
Hereditary Neoplastic Syndromes
Therapeutics
All Science Journal Classification (ASJC) codes
- Medicine(all)
Cite this
Diab, O., Chintalacheruvu, L. M., & Lynch, H. T. (2017). Therapeutic and preventive implications of moonshot in hereditary cancer syndromes. JAMA oncology, 3(5), 592-593. https://doi.org/10.1001/jamaoncol.2016.3046
Therapeutic and preventive implications of moonshot in hereditary cancer syndromes. / Diab, Osama; Chintalacheruvu, Lakshmi Manogna; Lynch, Henry T.
In: JAMA oncology, Vol. 3, No. 5, 2017, p. 592-593.Research output: Contribution to journal › Short survey
Diab, O, Chintalacheruvu, LM & Lynch, HT 2017, 'Therapeutic and preventive implications of moonshot in hereditary cancer syndromes', JAMA oncology, vol. 3, no. 5, pp. 592-593. https://doi.org/10.1001/jamaoncol.2016.3046
Diab O, Chintalacheruvu LM, Lynch HT. Therapeutic and preventive implications of moonshot in hereditary cancer syndromes. JAMA oncology. 2017;3(5):592-593. https://doi.org/10.1001/jamaoncol.2016.3046
@article{2729559efd094961a21897c831fe6563,
title = "Therapeutic and preventive implications of moonshot in hereditary cancer syndromes",
author = "Osama Diab and Chintalacheruvu, {Lakshmi Manogna} and Lynch, {Henry T.}",
year = "2017",
doi = "10.1001/jamaoncol.2016.3046",
language = "English (US)",
volume = "3",
pages = "592--593",
journal = "JAMA oncology",
issn = "2374-2437",
publisher = "American Medical Association",
number = "5",
}
TY - JOUR
T1 - Therapeutic and preventive implications of moonshot in hereditary cancer syndromes
AU - Diab, Osama
AU - Chintalacheruvu, Lakshmi Manogna
AU - Lynch, Henry T.
PY - 2017
Y1 - 2017
UR - http://www.scopus.com/inward/record.url?scp=85020100146&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85020100146&partnerID=8YFLogxK
U2 - 10.1001/jamaoncol.2016.3046
DO - 10.1001/jamaoncol.2016.3046
M3 - Short survey
VL - 3
SP - 592
EP - 593
JO - JAMA oncology
JF - JAMA oncology
SN - 2374-2437
IS - 5
ER -